Your browser doesn't support javascript.
loading
Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash, G I; White, H D; Modan, M; Diaz, R; Hampton, J R; Heikkila, J; Kristinsson, A; Moulopoulos, S; Paolasso, E A; Van der Werf, T.
Affiliation
  • Barbash GI; Department of Cardiology, Tel Aviv-Elias Sourasky Medical Center, Israel.
Arch Intern Med ; 154(19): 2237-42, 1994 Oct 10.
Article in En | MEDLINE | ID: mdl-7944845
Subject(s)
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Streptokinase / Heparin / Thrombolytic Therapy / Outcome Assessment, Health Care / Cardiology Service, Hospital / Tissue Plasminogen Activator / Health Facility Size / Myocardial Infarction Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Arch Intern Med Year: 1994 Document type: Article
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Streptokinase / Heparin / Thrombolytic Therapy / Outcome Assessment, Health Care / Cardiology Service, Hospital / Tissue Plasminogen Activator / Health Facility Size / Myocardial Infarction Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Arch Intern Med Year: 1994 Document type: Article